and antibodies-online). Moreover, nanobodies are usually detected by mean of recombinant tags, added at one of their ends like 6×His, c-Myc, glutathione S-transferase (GST) or hemagglutinin (HA) [18] . Most of these tags have commercialized antibodies which differ certainly in their optimal working conditions and concentrations. Here, we have characterized a purified polyclonal rabbit anticamel antibody which represents an interesting tool for detecting all camel IgG subclasses as well as their derived nanobodies.
Materials and Methods

Purification of Rabbit polyclonal antibodies
Polyclonal rabbit antibodies (rIgGs) were purified from 2 ml of commercial rabbit serum by affinity chromatography on a 5 ml HiTrap protein A column (GE Life Science) according to the manufacturer's instructions. Binding was performed in 0.02 M sodium phosphate (pH 7), and rabbit IgG was eluted with 0.1 M citric acid (pH 3). Eluted IgG was collected and immediately neutralized to physiological (pH 9), with 1 M Tris-base buffer. After purification, rIgG was dialyzed and then concentrated on a Vivaspin concentrator with a molecular mass cutoff of 50 kDa (Vivascience) to 1 mg/ml and stored at -20°C in phosphate buffer containing 50% glycerol.
ELISA
An indirect ELISA format was employed for the analysis of commercial immunized rabbit sera and the detection of camel antibody subclasses. Maxisorp 96-well plates (Nunc) were coated overnight at 4°C with conventional IgG-1, heavy chain camel antibodies IgG-2 and IgG-3 (0.2-1 μg/well), and nanobody mix (0.25 μg/well) diluted in carbonate buffer. After coating, ELISA plates were washed 3 times with washing buffer TBS−T (20 mM Tris-base, 150 mM NaCl, 0.05% Tween-20, pH 7.5). Residual protein binding sites in the wells were blocked for 1 h at 37°C with 5× blocking buffer (3% skimmed milk and 1% BSA) in TBS-T. After the removal of blocking buffer, the indicated dilutions of purified rabbit anti-camel rIgG or anti-llama (kindly provided by Prof. Serge Muyldermans, Vrije Universiteit Brussel), were prepared in 1× blocking buffer and added in the wells for 1 hour at RT. After 3 washes, detection of rabbit polyclonals was performed by 1 h incubation at RT with goat anti-rabbit conjugated to HRP that make it more hydrophilic, promote their flexibility and solubility [7, 8] . The recombinant form of VHH, also known as Nanobody ® , possesses many unique features such as small size and the ability to recognize epitopes which are otherwise incompatible with classical antibodies [9] . In addition, amino acid substitutions in VHHs can explain the high stability of their corresponding nanobodies in expressing Escherichia coli, where they can be produced economically as soluble and non-aggregating proteins [10, 11] . Nanobodies, because of their single domain nature, offer several advantages for biotechnological and medical applications.
Nanobodies are procured by cloning their genetic repertoire from B cells circulating in the blood of an immunized camel, constructing a cDNA library and panning by phage display [10, 12] . Several published reports described the involvement of HCAbs in camelid immunity, especially in the response to pathogenic antigens [4, 13, 14] . Hence, after camel immunization with the antigen of interest, and during antibody purification, three fractions containing IgGs of distinct molecular weight can be isolated from the dromedary serum by differential adsorption on protein-A and protein-G columns [15] . The so-called "IgG-1" subclass contains the conventional antibodies comprising two heavy and two light chains. The "IgG-2" and "IgG-3" subclasses contain HCAbs composed of heavy chains that are approximately 10 and 12 kDa smaller than the heavy chain of conventional antibodies [4] . The percentage of HCAbs and conventional IgG in the sera of camelids is variable; in camels it might reach 50-80%, whereas in South American camelid species, it totals up to 10-25% [16] . The participation of HCAb subclasses in the antigen-inducing immune response, as manifested in antigen recognition in ELISA, is an important indication of a good camel immunizing process, since nanobodies are derived from the variable domain of these subclasses. Such information is indispensable before constructing an expensive and laborious nanobody "immune" library.
A limiting factor for investigations into camel immunity has been a shortage of well-characterized, isotypespecific reagents. One of the key components in ELISA and in various detection systems during this procedure is the specific antibody used against camel IgGs to evaluate the raised immune response and the participation of HCAbs. The production of several monoclonal antibodies specific to different subclasses of llama IgGs have been described, but failed in detecting camel IgGs [17] . Furthermore, testing retrieved nanobodies from the library against their antigens requires specific antibodies. Generally, camel IgGs are detected by anti-camel anti-serum produced mainly from rabbit (Bethyl Laboratories, Inc.
was carried out to 0.25 μg of different camel subclasses antibodies (IgG1, IgG2, IgG3) and pure nanobodies mixture was then blotted onto 0.45 μm nitrocellulose membranes (BioRad) using 1× blotting buffer (25 mM Tris-base, 200 mM glycine, 0.1% SDS and 20% methanol). After incubation in blocking buffer, membranes were incubated with the indicated dilutions of the rabbit anti-camel (1:1000) for 1 h at RT. After several washes with TBS-T, blots were finally incubated with goat anti-rabbit AP conjugated antibodies (Bethyl Laboratories Inc.) at dilution 1:2000 for 1 h at RT. Bands revelation was achieved by adding chromogen substrate (0.05% NBT and 0.025% BCIP; Sigma) in AP buffer (100 mM Tris-base, 100 mM NaCl, 5 mM MgCl 2 , pH 9.5).
Nanobody detection by competitive ELISA
Apparent detection affinity was determined by competitive indirect ELISA testing. In brief, nanobody mixture (0.2 μg/ well) was prepared in carbonate buffer and coated in 96-well ELISA plate at 4°C overnight. After blocking and washing, nanobody titrations (1 to 100 ng/ml), previously incubated with rabbit anti-camel rIgG (1:1000) for 1 h at RT, were added (100 μl) to the wells and incubated for an additional 1 h at RT. Plates were washed and bound rabbit anti-camel antibodies were detected with a goat antirabbit-HRP conjugate antibody (1:3000). The absorption at 450 nm was measured 15 min after adding the enzyme substrate TMB for peroxidase conjugates.
Dot blotting
Different antigens of recombinant human growth hormone (rhGH) from previous work [12] were immobilized on nitrocellulose membrane by spotting 2 μl (1 μg) of the samples at the center of the grid, and the membrane was left to dry. Blocking was conducted with 5× blocking buffer in TBS-T, then spots were treated with or without NbGH01 nanobody (1/500) [12] then with different antibodies: R-anti-camel rIgG (1:1000), R-anti6×His (Bethyl Laboratories Inc., 1:5000), R-anti-GFP (homemade, 1:3000) [20] , and R-anti-GH (homemade, 1:3000) [21] . After three washes with TBS-T, primary antibodies were detected with secondary conjugated AP goat anti-rabbit (1:3000). Spots revelation was achieved by adding chromogen substrate NBT/BCIP in AP buffer as described previously.
(Bethyl Laboratories Inc.) at 1:3000 in 1× blocking buffer. After 5 additional washes, bound conjugate was detected with 3,3′,5,5′−tetramethylbenzidine (TMB) substrate (Sigma), the reaction was stopped after 10 minutes with the addition 1 M H 2 SO 4 . The spectroscopic absorbance of the enzymatic reaction was measured in an automated plate reader at a wavelength of 450 nm.
Fractionation of IgG subclasses
An automated protocol to separate different IgG subclasses from the 5 ml camel plasma was setup using the AKTAprime (GE Healthcare) fast protein liquid chromatography system (FPLC). This was performed by differential adsorption on Hitrap protein-A and Hitrap protein-G columns (GE Healthcare) as described previously [4, 19] . Briefly, 5 ml camel serum was diluted with an equal volume of PBS and loaded at a flow rate of 5 ml/min on the protein-G column (5 ml) equilibrated with PBS. The flow-through was collected as this part contained the IgG-2 subclass of antibodies that do not adsorb on protein-G. After a column-volume washing with PBS, IgG-3 was eluted with buffer A (150 mM NaCl, 0.58% acetic acid, pH 3.5), IgG-1 was then eluted with buffer B (100 mM glycine-HCl, pH 2.7). The column was washed intensively with PBS and the flow through was reloaded on the column to remove the residual IgG-1 and IgG-3 of the flow through (as all IgGs from camel bind to protein A). The flow through was captured and loaded on PBS equilibrated protein A column, IgG-2 was eluted from the column using buffer A. Monitoring the UV absorption at 280 nm facilitated fractionation and sample collection. Once eluted, all IgG fractions were neutralized with 1.0 M Tris pH 9.0, dialyzed with PBS, quantified, diluted to 1 mg/ml, aliquoted and stored at −20°C. The integrity and the purity of IgG fractions were verified by loading a sample of 2 μg protein (denatured and reduced) onto a 15% polyacrylamide SDS gel, followed by coomassie blue staining.
Immunoblotting and coomassie blue staining of SDS-PAGE
SDS-PAGE was performed using Bio-Rad mini-Protean II system following the manufacturer's instructions. Gels were prepared using stacking gel 5% and running gel 15%. After electrophoresis, the gel was stained with coomassie blue for 2 h followed by destaining in 5% acetic acid and 10% methanol. For immuno-blotting, separation prepared as 1 mg/ml stock (data not shown). Furthermore, indirect ELISA showed that purified rIgG was reactive toward immobilized cIgGt ( Fig. 2A) . Interestingly, rIgG was able to detect similarly, but to a lesser extent, an immobilized mixture of pure nanobodies, since they were originally derived from the variable region of camel HCAb ( Fig. 2A) . Detection sensitivity of rIgG was tested toward
Results
Purification of rabbit anti−camel IgG
One interesting and commercial product for the detection of camel IgG (cIgG) that are bound to their inducing antigen during immune response evaluation, is a rabbit anti-camel serum from a commercial source (Bethyl Laboratories Inc.). It represents an efficient tool for the detection of cIgG with a titer exceeding 1/100000 (data not shown). Rabbit IgG (rIgG) from this serum was purified by affinity chromatography using protein-A column. An automated purification procedure was established using AKTA prime fast liquid protein chromatography (FPLC) system, allowing a direct and confirmed purification of total they from 2 ml rabbit serum (Fig. 1A) . A second purification step on protein-A column is necessary to assure the total purification of rIgGs from the serum flowthrough (Fig. 1B) .
Reactivity of purified rabbit anti-camel IgG
In order to test the reactivity of purified rIgG, total IgG was purified from 5 ml camel serum (cIgGt) using the same previous affinity purification method and was also decreasing concentrations (ng/ml) of immobilized cIgGt or nanobodies by indirect ELISA (Fig. 2B) . Using this method, rIgG was able to detect low concentrations of cIgGt (linear range from 3 to 100 ng/ml) and nanobodies at a concentration ten times greater.
Purification of camel IgG subclasses for testing against rIgG
In order to evaluate the reactivity of rIgG for the different subclasses of camel cIgG, rIgG were prepared from 5 ml blood serum of an immunized camel with rhGH. The cIgG subclasses (IgG-1, 2 and 3) were fractionated from the serum sample by differential adsorption on protein-G and protein-A columns (Fig. 3A) . IgG-1 and IgG-3 can be purified directly from camel serum by adsorption on protein-G column and through two steps of elution (Fig. 3A, left  panel) . An intermediate purification step on protein-G column is necessary to assure the total purification of these two cIgGs from the serum flow-through (Fig. 3A, middle  panel) , before further purification of cIgG-2 on protein-A column from this flow-through (Fig. 3A, right panel) . The integrity and purity of these fractions were visualized by SDS-PAGE (15%) followed by staining with coomassie blue (Fig. 3B) . Expectedly, cIgG-1 as conventional antibody showed two distinct bands: one of the heavy chains (~55 kDa) and a smaller one of the light chains (~25kDa), whereas, HCAbs (IgG-2 and 3) showed smaller single bands related to their heavy chains which lack the CH1 domain. The band of cIgG-2 (~50 kDa) was notably bigger than that of cIgG-3 (~45kDa) because of the long hinge region characterizing this subclass of antibodies (Fig 3B) . SDS-PAGE-loaded nanobody mixture appeared as a single small band of ~15 kDa (Fig. 3B ).
Reactivity of rIgG against camel subclasses and nanobodies
As a polyclonal antibody, rIgG was able to detect all different chains from the three subclasses when incubated with the nitrocellulose blot of the transferred samples from SDS-PAGE in the same order as shown in the first blue-stained gel (Fig. 3C) . In confirmation of our previous result in ELISA, rIgG detected nanobodies, despite being denatured during sample preparation before loading on the gel. Furthermore, using the same amount for immobilization, rIgG was able to detect similarly all three subclasses of cIgG in indirect ELISA and, to a lesser extent, the nanobody mixture (Fig. 4A) . The reactivity of our anti-camel rIgG was higher than anti-llama rIgG which recognized equally all three different cIgG subclasses but not the nanobodies (Fig. 4A) .
Quantitation of nanobodies using rIgG in a competitive ELISA
To test whether anti-camel rIgG can be used in nanobody quantification, a competitive indirect ELISA was conducted by its incubation with serial logarithmic dilutions of free nanobodies (fNb). Bound rIgG/fNb complexes were then added to a 96-well microplate, pre-coated with immobilized nanobodies. The more free nanobodies in the reaction, the less rIgG will be available to bind to immobilized nanobodies in the wells, hence a weaker signal in ELISA, and vice versa (Fig. 4B) . incubated in the presence of rIgG (Fig. 5A) . Interestingly, rabbit anti-camel rIgG succeeded in similarly recognizing the antigen-bound cIgG in the positive crude serum (after immunization) and in all pure subclasses, recognizing at the same time the bound specific nanobody and not the control. Impressively, the background signals in control or empty wells were very weak using pure rIgG for the detection of cIgG as compared with rabbit anti-camel crude serum (data not shown).
Testing the background of nanobody detection using dot blotting
To confirm the utility of the anti-camel rIgG in the detection of nanobody bound to its specific recombinant
Detection of antigen-bound cIgG and nanobodies using rabbit anti-camel rIgG
Finally, indirect ELISA was performed to test the capacity of anti-camel rIgG to efficiently detect different subclasses of cIgG and the nanobodies when they are bound to their specific antigen. For this aim, the microplate was coated with rhGH (0.25 μg/ml) before adding diluted (1/10000) crude serum samples from before (S0) and after eight weeks (S8) of camel immunization with the same recombinant protein. Also, diluted (1/500) cIgG subclasses (IgG-1, 2 and 3) as well as two different nanobodies (1/500)--a GH specific (Nb+) and negative control nanobody (Nb-)--were all added to the precoated wells and then 5 . Detection of antigen-bound antibodies and nanobodies using rabbit anti-camel IgG (A) Indirect ELISA for the detection of immobilized rhGH (0.25 µg/well) using camel serum (1/10000) from before (S0) and eight weeks (S8) after being immunized with rhGH, dilutions (1/500) of IgG1, IgG2, IgG3, NbGH01 (Nb+), NbGFP01 (Nb-) or left without antibodies (No Ab). Revelation was performed using rIgG (1/500). (B) Dot-blotting membranes using different antigens (below). Detection was performed in the presence or the absence of NbGH01. Several detecting polyclonal antibodies were used (to the right).
in this immune response, since these last are the true representatives of nanobodies in camel blood. A simple ELISA on the immobilized antigen could provide the answers for these questions using several dilutions of total camel serum or its IgG subclasses purified by differential affinity chromatography. One key element in such ELISA is the anti-camel detecting antibody, which must be very reactive and specific towards all camel IgG subclasses. We showed in this work that rabbit anti-camel antibody from Bethyl Laboratories Inc. might represent an interesting choice. Unfortunately, this antibody is commercialized as total rabbit serum, which imposes a first step of IgG purification. For the purification of rabbit IgG from serum we used protein-A sepharose affinity chromatography since protein-A column is the best candidate to isolate monoclonal and polyclonal IgG from ascites, serum, tissue culture and bioreactor supernatants. Protein A is a recombinant cell wall protein from the bacterium Staphylococcus aureus with an important binding affinity for the constant domains (CH) in the Fc fragment of immunoglobulins from different species [26, 27] . Also, protein-A and protein-G affinity chromatography are the fastest methods for purifying antibodies and protein-A purification is recommended for rabbit antibodies [28] .
Anti-camel rIgG may be considered as an alternative tool for the detection of nanobodies since all used secondary antibodies against nanobodies target their recombinant tags like anti-6×His tag antibody. Moreover, certain applications of nanobodies necessitate the elimination of these tags because of their undesirable side effects or their immunogenicity, making the detection of these nanobodies unachievable using regular antibodies. In addition, replacement of rIgG with a commercial rabbit anti-6×His tag, in ELISA detection of bound nanobody, was futile since immobilized recombinant antigen (rhGH) possesses the same tag as well (data not shown). This provides an interesting example for applying rIgG in nanobody detection when regular anti-tag antibodies are unusable.
The calculated EC 50 for anti-camel rIgG against cIgG was estimated of about 0.2 μg/ml (1/5000 dilution) and this value was ten time higher against immobilized nanobodies. Interestingly, rIgG was able to detect very low amounts (3 ng/well) of nanobodies by simple and competitive indirect ELISA. The last method has great potential in certain applications for quantitation of impure nanobodies within protein samples like total cell extracts. Furthermore, humanized and untagged nanobodies are the only formulations approved for medical administration in humans, thus anti-nanobody antibody that recognize the main polypeptide sequence of the protein, and not antigen comparing with a commercial anti-6×His antibody, a dot blot experiment was carried out. For this purpose, different recombinant antigens were spotted on a nitrocellulose membrane: rhGH, His-GH, GFP-GH, GFP, GFP-TEV, with PBS used as a negative control (Fig. 5 B) . After blocking, spots were incubated with an anti-GH nanobody (NbGH01), and bound nanobodies were detected either by anti-6×His antibody or the purified anticamel rIgG. In another case, spots were directly treated with these antibodies in the absence of nanobodies. As expected, the two methods for nanobody detection were able to detect bound NbGH01 to GH in its different forms. However, one confusing spot appeared using GFP-TEV as antigen when anti-6×His antibody was used for detection. This spot was not related to the nanobody as it was also observed in the absence of nanobody. It is explained by the capacity of this antibody to detect c-terminal 6×His tags in the recombinant proteins (like the nanobody itself), and GFP-TEV is the only immobilized antigen that possess the His tag at the c-terminal.
Discussion
It seems that the paratopes of HCAbs and conventional antibodies recognize different antigenic sites on their target. It is therefore possible that HCAbs have been selected and maintained in the camelid species for complementary function in their immune response [22] . Although knowledge of the exact roles and functions of the various camelid IgG subclasses is still in its infancy, an infected or vaccinated animal raises an immune response in the three isotype fractions (to various extents in different animals, depending on the actual immunogen). In a previous study, monoclonal antibodies (MAbs), specific for dromedary (Camelus dromedarius) IgG1 and IgM, have been produced and characterized to monitor the camel immune response [23] . Remarkably, the llama IgG1 and IgG3 neutralize West Nile virus, whereas IgG2 seems less effective in this respect [24] .
The antigen-binding fragments of HCAbs are comprised in a single-domain, referred to as VHH or Nanobody. They have a broad range of applications in biotechnical and therapeutic uses due to their small size, simple production and high affinity [25] . Nanobody production technology requires several checkpoints in order to evaluate the correct advancement of the procedure. For example, at the end of camel immunization, two questions are routinely asked, one regarding the rise of specific and powerful immune response against used antigen and the other about the participation of HCAbs the additive tags, is the only remaining method for the detection and the real quantitation of these nanobodies during manufacturing. The small portion of the anti-camel rIgG that recognizes nanobodies could be extracted using affinity chromatography on a special type of columns containing covalently immobilized nanobodies as capturing ligands. Furthermore, by a covalent conjugating of anti-camel rIgG to HRP or AP enzymes, the final step of immunoassays which requires conjugated secondary antibodies can be omitted [29] .
In summary, detection of camel conventional and heavy chain IgGs, as well as their derivative nanobodies, could be achieved using one single reagent: the anti-camel rIgG. Such a reagent has very important applications in nanobody technology, first in evaluating camel immune response, then in assessing HCAb participation in this response, and finally in testing the isolated nanobodies against their antigens using several immunoassays.
